Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia

Blood. 1992 Jul 15;80(2):560-1.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cyclosporine / therapeutic use*
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Graft vs Host Disease / prevention & control*
  • HLA Antigens / analysis
  • Histocompatibility Testing
  • Humans
  • Leukemia / surgery*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / surgery*
  • Leukemia, Myeloid, Acute / surgery*
  • Methotrexate / therapeutic use*
  • Time Factors

Substances

  • HLA Antigens
  • Cyclosporine
  • Methotrexate